KEDRAB 150 [iU]/mL
HUMAN RABIES VIRUS IMMUNE GLOBULIN · INJECTION, SOLUTION · Kedrion Biopharma Inc.
KEDRAB is a injection, solution containing human rabies virus immune globulin at 150 [iU]/mL, taken intramuscular. Manufactured by Kedrion Biopharma Inc..
Key Facts
- Brand Name
- KEDRAB
- Generic Name
- HUMAN RABIES VIRUS IMMUNE GLOBULIN
- NDC Code (Product)
76125-150- Manufacturer
- Kedrion Biopharma Inc.
- Strength
- 150 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125613
- Marketing Start
- 11/08/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is KEDRAB used for?
KEDRAB contains HUMAN RABIES VIRUS IMMUNE GLOBULIN. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is KEDRAB a controlled substance?
KEDRAB is not classified as a controlled substance by the DEA.
What is the generic name for KEDRAB?
The generic name for KEDRAB is HUMAN RABIES VIRUS IMMUNE GLOBULIN. There are no other listed brand versions of HUMAN RABIES VIRUS IMMUNE GLOBULIN.
What is the NDC code for KEDRAB 150 [iU]/mL?
The NDC (National Drug Code) for KEDRAB 150 [iU]/mL is 76125-150, listed by Kedrion Biopharma Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)